PRESS RELEASE published on 07/09/2024 at 20:45, 1 year 9 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its 2023 annual results, financial highlights, and financing outlook. Annual General Meeting scheduled for September 13, 2024 Annual General Meeting Financial Highlights 2023 Annual Results ACTICOR BIOTECH Financing Outlook
PRESS RELEASE published on 07/09/2024 at 20:45, 1 year 9 months ago Informations privilégiées / Communiqué sur comptes, résultats Acticor Biotech publie ses résultats financiers annuels pour 2023, avec une perte nette de 18,640 K€. La trésorerie s'élève à 3,9 M€. L'AG se tiendra le 13 septembre 2024 Résultats Financiers Assemblée Générale Trésorerie Perte Nette ACTICOR BIOTECH
BRIEF published on 05/15/2024 at 11:20, 1 year 10 months ago Résultats de l'étude ACTISAVE et perspectives futures d'ACTICOR BIOTECH ACTICOR BIOTECH Étude ACTISAVE Traitement AVC Glenzocimab ESOC 2024
BRIEF published on 05/15/2024 at 11:20, 1 year 10 months ago Results of the ACTISAVE study and future perspectives of ACTICOR BIOTECH Stroke Treatment ACTICOR BIOTECH Glenzocimab ESOC 2024 ACTISAVE Study
PRESS RELEASE published on 05/15/2024 at 11:15, 1 year 10 months ago Informations privilégiées / Autres communiqués ACTICOR BIOTECH présente les résultats de l'étude ACTISAVE sur le traitement de l'AVC ischémique lors de l'ESOC 2024. Perspectives prometteuses pour le glenzocimab malgré l'absence d'efficacité globale ACTICOR BIOTECH Glenzocimab ESOC 2024 AVC Ischémique ACTISAVE
PRESS RELEASE published on 05/15/2024 at 11:15, 1 year 10 months ago Inside Information / Other news releases ACTICOR BIOTECH presents main results of phase 2/3 ACTISAVE study on stroke treatment at ESOC 2024, targeting specific subgroups for potential benefits Stroke Treatment ACTICOR BIOTECH ESOC 2024 ACTISAVE Study Patient Subgroups
Published on 04/10/2026 at 13:00, 40 minutes ago Gamma Resources Adopts Semi-Annual Financial Reporting
Published on 04/10/2026 at 13:00, 40 minutes ago GMV Minerals Announces Drill Mobilization at the Mexican Hat Gold Deposit in S.E. Arizona
Published on 04/10/2026 at 02:15, 11 hours 25 minutes ago Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Published on 04/10/2026 at 01:05, 12 hours 35 minutes ago Pathfinder Ventures Inc. Announces Tranche Closing of Financing and Extension of Private Placement
Published on 04/10/2026 at 00:00, 13 hours 40 minutes ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/10/2026 at 13:28, 11 minutes ago Ethnosports 2027 unveiled as a global vision for traditional sports
Published on 04/10/2026 at 11:45, 1 hour 54 minutes ago EQS-Adhoc: Bastei Lübbe AG lowers revenue and EBIT forecast for the 2025/2026 financial year
Published on 04/10/2026 at 11:07, 2 hours 32 minutes ago NOTICE OF CALLING OF THE ORDINARY SHAREHOLDERS’ MEETING
Published on 04/10/2026 at 10:45, 2 hours 54 minutes ago "In Europe, For Europe": Haier Biomedical Spotlights Full-Scenario Lab Solutions at analytica Munich 2026
Published on 04/10/2026 at 11:07, 2 hours 32 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 31 mars 2026
Published on 04/10/2026 at 10:00, 3 hours 40 minutes ago Recticel Group akoestische materialen gebruikt in NASA’s Artemis II-missie
Published on 04/10/2026 at 10:00, 3 hours 40 minutes ago Recticel Group’s acoustic materials used in NASA’s Artemis II-mission
Published on 04/10/2026 at 08:45, 4 hours 55 minutes ago Imerys-communique-presse-accord-ferme_10-04-2026_VFR
Published on 04/10/2026 at 08:45, 4 hours 55 minutes ago Imerys-press-release-binding-agreement_10-04-2026_VENG
